← Back to Search
Preparation Of Desmopressin-containing Liposomes For Intranasal Delivery.
S. Law, K. Huang, H. Y. Chou
Published 2001 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
The loading and leakage characteristics of the desmopressin-containing liposomes and the effect of liposomes on the nasal mucosa permeation and antidiuresis of desmopressin were investigated. Higher loading efficiency of desmopressin for positively charged liposomes than negatively charged liposomes was obtained, and neutral liposomes resulted in a similar loading efficiency as that of positively charged liposomes. Greater leakage of desmopressin from negatively charged liposomes than from positively charged and neutral liposomes was shown. The increase of permeability of desmopressin through the nasal mucosa indicated positively charged liposomes>negatively charged liposomes>solution. It was suggested that the enhanced contact time of positively charged liposomes with negatively charged nasal mucosa led to a high local desmopressin concentration on the penetration site to promote an effective penetration of desmopressin through the nasal mucosa. The desmopressin antidiuresis result after intranasal administration was in good agreement with the permeability result in the order of positively charged liposomes>negatively charged liposomes>solution. One of the mechanisms for the explanation of the best result on the enhancement of antidiuresis for positively charged liposomes may be the bioadhesive effect of the liposomes on the negatively charged nasal mucosa.
This paper references
Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin.
A. Harris (1989)
Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin.
A. Harris (1986)
Prodrugs of Peptides. 18. Synthesis and Evaluation of Various Esters of Desmopressin (dDAVP)
A. H. Kahns (2004)
Basic Pharmacology of Desmopressin
H. Vilhardt (1990)
Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors
Hong-Shian Huang (1983)
Effects of Viscous Hyaluronate–Sodium Solutions on the Nasal Absorption of Vasopressin and An Analogue
K. Morimoto (2004)
Permeability of insulin entrapped in liposome through the nasal mucosa of rabbits.
Y. Maitani (1992)
Colorimetric determination of phospholipids with ammonium ferrothiocyanate.
J. C. Stewart (1980)
The nature of the hydrophobic binding of small peptides at the bilayer interface: implications for the insertion of transbilayer helices.
R. Jacobs (1989)
Interactions of small polypeptides with dimyristoylphosphatidylcholine monolayers: effect of size and hydrophobicity
N. Williams (1989)
Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans.
H. Vilhardt (1986)
Pharmacokinetics of 1‐deamino‐8‐d‐arginine vasopressin after various routes of administration in healthy volunteers
A. Fjellestad-Paulsen (1993)
Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids.
A. S. Ladokhin (1997)
Nasal Absorption of Desmopressin in Rats and Sheep. Effect of a Bioadhesive Microsphere Delivery System
H. Critchley (1994)
Characterization of calcitonin-containing liposome formulations for intranasal delivery.
S. Law (2001)
Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin.
A. Harris (1988)
Preparation and characterization of doxorubicin-containing liposomes. II. Loading capacity, long-term stability and doxorubicin-bilayer interaction mechanism
D. Crommelin (1983)
The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits.
K. Muramatsu (1999)
Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.
V. Lee (1991)
Release characteristics of mitoxantrone-containing liposomes
S. Law (1994)
Degradation of [mercaptopropionic acid1, D-arginine8]-vasopressin (dDAVP) in pancreatic juice and intestinal mucosa homogenate.
S. Lundin (1989)
Pharmacokinetics and haematological effects of desmopressin
M. Koehler (2004)
Mechanism of liposome destabilization by polycationic amino acids
R. Epand (1995)
Influence of bile salts on the permeability of insulin through the nasal mucosa of rabbits in comparison with dextran derivatives
N. Uchida (1991)
Influence of liposomes on tryptic digestion of insulin.
Y. Katô (1993)
Studies of synthetic peptide analogs of the amphipathic helix. Effect of charged amino acid residue topography on lipid affinity.
P. Kanellis (1980)
This paper is referenced by
Development of risperidone liposomes for brain targeting through intranasal route.
Reema Narayan (2016)
Development of a Liposome Formulation for D-Cycloserine Local Delivery
T. Musumeci (2008)
Neuroprotective peptide drug delivery and development: potential new therapeutics
I. Gozes (2001)
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate.
F. Bortolotti (2009)
In vitro evaluation of intestinal absorption of desmopressin using drug-delivery systems based on superporous hydrogels.
A. Polnok (2004)
Development and Validation of a Reversed-Phase High-performance Liquid Chromatography Method for Determination of Desmopressin in Chitosan Nanoparticles
Seyed Mojtaba Taghizadeh (2013)
ENHANCEMENT OF NASAL ABSORPTION OF CALCITONIN LOADED IN LIPOSOMES
S. Law (2001)
DEVELOPMENT AND EVALUATION OF LIPOSOMAL MUCOADHESIVE GEL FOR NASAL DELIVERY OF ACYCLOVIR
Amel Y. Hamed (2008)
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR DESMOPRESSIN FROM POLYMERIC NANOPARTICLES
Dipti Desai (2016)
Intranasal desmopressin administration
Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
Yasmine M Gabal (2014)
Nasal Delivery of High Molecular Weight Drugs
Y. Ozsoy (2009)
RECENT TECHNIQUES IN NASAL DRUG DELIVERY: A REVIEW
Parmar Harshad (2010)
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate
Bortolotti Fabrizio (2009)
Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule.
Lamis H Salem (2020)
Multilamellar liposomes of triamcinolone acetonide: preparation, stability, and characterization
B. Clares (2009)
Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
D. Libster (2011)
Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations.
M. Migliore (2010)
Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation
M. M. Omar (2019)
Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil
Abdulrahman K Al Asmari (2016)
Stability of Desmopressin Loaded in Liposomes
S. Law (2003)
Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation.
I. Alsarra (2008)
Recent Advances and Novel Approaches for Nose to Brain Drug Delivery for Treatment of Migraine
Nidhi Sachan (2019)
To Study Effect of Process Variables on Preparation of Desmopressin Loaded Nanoparticles Using Box-Behnken Design
D. Desai (2016)
Acyclovir Liposomes for Intranasal Systemic Delivery: Development and Pharmacokinetics Evaluation
I. Alsarra (2008)
Thiomers: The Next Generation of Mucoadhesive Polymers
Andreas Bernkop-Schn rch (2005)
Nasal and Pulmonary Delivery of Macromolecules to Treat Respiratory and Nonrespiratory Diseases
D. Paturi (2012)
Lamotrigine encapsulated intra-nasal nanoliposome formulation for epilepsy treatment: Formulation design, characterization and nasal toxicity study.
Arshiya Praveen (2019)
Nasal Drug Delivery
P. Karla (2008)
Thiomers in noninvasive polypeptide delivery: in vitro and in vivo characterization of a polycarbophil-cysteine/glutathione gel formulation for human growth hormone.
V. Leitner (2004)
Intranasal delivery of GDNF for the treatment of Parkinson's Disease
M. Migliore (2008)
Mahmoud Mohamed Omar (2019)See more